Wikisage, the free encyclopedia of the second generation, is digital heritage
Iscador: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(todo) |
||
| Line 1: | Line 1: | ||
Mistletoe (Iskador mali) a preparation of Viscum album [[Carl von Linné|L.]]) off-label. Since decades Mistletoe has been used in European medicine for oncology<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052504/ Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study] </ref>Mistletoe lectins (e.g. Iscador Q [[viscotoxin]]) have been identified as main active components and exhibit cytotoxic effects as well as immunomodulatory activity<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485514/ Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas]</ref> | Mistletoe (Iskador mali) a preparation of [[Viscum album]] [[Carl von Linné|L.]]) off-label. Since decades Mistletoe has been used in European medicine for oncology<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052504/ Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study] </ref>Mistletoe lectins (e.g. Iscador Q [[viscotoxin]]) have been identified as main active components and exhibit cytotoxic effects as well as immunomodulatory activity<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485514/ Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas]</ref> | ||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133960/ Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients] | <ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133960/ Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients] | ||
</ref> | </ref> | ||
Revision as of 16:31, 5 December 2015
Mistletoe (Iskador mali) a preparation of Viscum album L.) off-label. Since decades Mistletoe has been used in European medicine for oncology[1]Mistletoe lectins (e.g. Iscador Q viscotoxin) have been identified as main active components and exhibit cytotoxic effects as well as immunomodulatory activity[2] [3]
Büssing et Ostermann (2012[4]) found some evidence for moderate improvement of quality of life associated with Iscador treatment (Weleda[5]). [6] Pine mistletoe extract (Iscador P Viscum album austriacus) can be used on equine sarcoids as safe and effective treatment.[7]
Links
References
- ↑ Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study
- ↑ Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas
- ↑ Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients
- ↑ Quality of Life and Related Dimensions in Cancer Patients Treated with Mistletoe Extract (Iscador): A Meta-Analysis
- ↑ Iscador Newsletter summer 2015
- ↑ Quality of Life and Neutropenia in Patients with Early Stage Breast Cancer: A Randomized Pilot Study Comparing Additional Treatment with Mistletoe Extract to Chemotherapy Alone
- ↑ Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus)
- ↑ Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?